97222 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
Sub-classes:MULTISPECIFIC MOLECULES FOR CLEARANCE OF IMMUNOGLOBULINS IN THE TREATMENT OF AUTOANTIBODY-INDUCED DISEASES
#2IMMUNOASSAY METHOD, NON-SPECIFIC REACTION SUPPRESSION METHOD, IMMUNOASSAY REAGENT, IMMUNOASSAY REAGENT KIT, COMPOSITION, NON-SPECIFIC REACTION SUPPRESSING AGENT, AND USE
#3ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF
#4ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF
#5SLITRK6 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
#6PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION
#7COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC THERAPY
#8ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#9USE OF IMMUNOSUPPRESSION TO ENABLE ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS
#10MINI BODIES AS VACCINES FOR HIV
#11HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
#12ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES THEREOF
#13COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#14HUMANIZED OR CHIMERIC CD3 ANTIBODIES
#15MODULAR PLATFORM FOR TARGETED THERAPEUTICS
#16ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE
#17MIMOTOPES OF ALPHA-SYNUCLEIN AND VACCINES THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHY
#18ANTIBODY FOR NEUTRALIZING SUBSTANCE HAVING COAGULATION FACTOR VIII (F.VIII) FUNCTION-SUBSTITUTING ACTIVITY
#19ANTI-PACAP ANTIBODIES AND USES THEREOF
#20METHOD FOR PRODUCING PARTICLES
#21HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)
#22Anti-PACAP antibodies and uses thereof
#23MOUSE MONOCLONAL ANTIBODIES AGAINST GALACTOSE-DEFICIENT IGA1,PREPARATION METHOD THEREOF, AND USE THEREOF
#24Anti-polymeric IgA antibodies and methods of use
#25SERUM ALBUMIN-BINDING IMMUNOGLOBULIN VARIABLE DOMAINS
#26HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF
#27Anti-idiotypic antibodies against anti-KLK2 antibodies
#28REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF
#29Rabbit antibodies to human immunoglobulins G
#30Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion
#31Methods of treatment with anti-PACAP antibodies
#32Methods of use of CD24 for the prevention and treatment of leukemia relapse
#33Anti-BCMA CAR antibodies, conjugates, and methods of use
#34Antibodies useful for detection of human carcinoma antigen
#35CH3 DOMAIN EPITOPE TAGS
#36ANTI-PACAP ANTIBODIES
#37Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies
#38COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
#39Monoclonal antibody specifically binding to human plasmalemma vesicle-associated protein PV-1, preparation and use thereof
#40Monoclonal antibody against IgM and non-specific reaction inhibitor
#41COMPLEX-SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS AND ITS USE
#42Antibodies against 4G7-derived chimeric antigen receptors
#43REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIa ANTIBODIES AND USES THEREOF
#44Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy
#45Humanized or chimeric CD3 antibodies
#46Humanized anti-PACAP antibodies
#47Humanized anti-PACAP antibodies
#48Anti-PACAP antibodies
#49Humanized anti-ACTH antibodies and use thereof
#50Humanized anti-PACAP antibodies
#51HUMANIZED OR CHIMERIC CD3 ANTIBODIES
#52Anti-PACAP antibodies
#53HUMANIZED IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#54Modular platform for targeted therapeutics
#55SEQUENCING-DIRECTED SELECTION OF TUMOR THERANOSTICS
#56Composition and methods of treating B cell disorders
#57Methods of determining whether anti-PACAP antibodies inhibit PACAP-associated photophobia or light aversion
#58FC VARIANTS WITH ENHANCED BINDING TO FCRN AND PROLONGED HALF-LIFE
#59Antibodies useful for detection of human carcinoma antigen
#60Methods of treating cancer with human monoclonal antibodies against interleukin 8 (IL-8)
#61Anti-PACAP antibodies and uses thereof
#62Humanized anti-ACTH antibodies and use thereof
#63Humanized Anti-HLA-DR Antibodies
#64Serum albumin-binding immunoglobulin variable domains
#65Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies
#66Human monoclonal antibodies against interleukin 8 (IL-8)
#67METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#68Complex-specific antibodies and antibody fragments and its use
#69Reversal binding agents for anti-factor XI/XIa antibodies and uses thereof
#70ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#71Human monoclonal antibodies against interleukin 8 (IL-8)
#72Anti-PACAP antibodies and uses thereof
#73Humanized anti-PACAP antibodies and uses thereof
#74Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#75Method of making patient specific anti-idiotype antibodies
#76Humanized monoclonal antibodies and methods of use
#77Humanized anti-HLA-DR antibodies
#78ANTI-PACAP ANTIBODIES AND USES THEREOF
#79Use of anti-pacap antibodies and antigen binding fragments thereof for treatment, prevention, or inhibition of photophobia
#80Anti-MIF immunohistochemistry
#81Humanized or chimeric CD3 antibodies
#82Anti-PACAP antibodies
#83Anti-TNF antibodies, compositions, methods and uses
#84Humanized anti-ACTH antibodies and use thereof
#85Humanized or chimeric CD3 antibodies
#86Humanized immunobinders of cell-surface antigens
#87Single domain antibodies directed against STAT3
#88Single domain antibodies directed against KRAS
#89Single domain antibodies directed against TNF-alpha
#90Method for diagnosis and prognosis of chronic obstructive pulmonary disease (COPD)
#91MOLECULES AND METHODS FOR TREATMENT OF DIABETES
#92Method for refolding antibody, process for producing refolded antibody, refolded antibody, and uses thereof
#93Anti-human IgG1 antibody
#94Complex-specific antibodies and antibody fragments and its use
#95ANTIBODIES COMPRISING SEQUENCES FROM CAMELIDAE TO HIGHLY CONSERVED TARGETS
#96Compositions and methods comprising binding proteins for adalimumab
#97Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
#98Method of isolating human antibodies
#99HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)
#100Immunological Compositions as Cancer Biomarkers and/or Therapeutics
#101ANTI-HUMAN IgG1 ANTIBODY
#102Antigen-binding protein directed against epitope in the CH1 domain of human IgG antibodies
#103Anti-idiotype antibody against an antibody against the amyloid β peptide
#104Molecules mimicking an autoantibody idiotype and compositions containing same
#105Humanized monoclonal antibodies and methods of use
#106ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE
#107Prevention and treatment of cast nephropathy
#108MOLECULES AND METHODS FOR TREATMENT OF DIABETES
#109Ganglioside epitopes for treating Guillain-Barre syndrome
#110METHOD OF DETECTING RAW PORK AND DETECTION KIT THEREFOR
#111METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS
#112Anti-TNF antibodies, compositions, methods and uses
#113Methods of treating lupus
#114Therapeutic using a bispecific antibody
#115Methods of treating cancer with human monoclonal antibodies against interleukin 8
#116ANTI-IL-6 ANTIBODIES,COMPOSITIONS, METHODS AND USES
#117Neoplasia-Specific Autoantibodies and Methods
#118SPECIFIC BINDING PROTEINS AND USES THEREOF
#119ANTI-IL-6 ANTIBODIES, COMPOSITIONS, METHODS AND USES
#120Assays for detecting antibodies specific to therapeutic anti-IgE antibodies and their use in anaphylaxis
#121Ganglioside epitopes for treating guillain-barre syndrome
#122Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#123MOLECULES AND METHODS FOR TREATMENT OF DIABETES
#124IMMUNOGLOBULIN PREPARATION FOR THE TREATMENT OF HIV-1 INFECTION
#125Human monoclonal antibodies against interleukin 8 (IL-8)
#126Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#127Methods for identifying immunobinders of cell-surface antigens
#128Immunological compositions as cancer biomarkers and/or therapeutics
#129Humanized L243 antibodies
#130Humanized anti-HLA-DR antibodies
#131Anti-idiotype antibody against an antibody against the amyloid β peptide
#132Anti-autoimmune antibodies for treatment of pemphigus
#133PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#134Anti-IL-6 antibodies, compositions, methods and uses
#135Methods and Compositions Comprising Anti-Idiotypic Antibodies to Anti-MMP-14 Antibodies
#136Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the C1 domain of Factor VIII
#137Anti-TNF antibodies, compositions, methods and uses
#138ANTIBODIES AND USES THEREOF
#139Anti-TNF antibodies, compositions, methods and uses
#140Anti-TNF antibodies, compositions, methods and uses
#141Compositions and methods comprising binding proteins for adalimumab
#142Anti-IL-6 antibodies, compositions, methods and uses
#143ANTIBODIES AND USES THEREOF
#144Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
#145Anti-Idiotypic Antibodies Neutralizing the Inhibitory Activity of an Inhibitory Antibody Directed Against the C1 Domain of Factor VIII
#146Human monoclonal antibodies against interleukin 8 (IL-8)
#147PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#148Anti-IL-6 antibodies, compositions, methods and uses
#149Antibodies with altered effector functions
#150PRODUCTION OF ANTI-SELF ANTIBODIES FROM ANTIBODY SEGMENT REPERTOIRES AND DISPLAYED ON PHAGE
#151Therapeutic using a bispecific antibody
#152Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
#153Treatment of B cell diseases using anti-germline antibody binding agents
#154Anti-idiotypic antibody neutralizing the inhibitor activity of a factor VIII inhibitor antibody
#155Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof
#156Humanized L243 antibodies
#157Anti-IL-6 antibodies, compositions, methods and uses
#158Polypeptides that bind an anti-tissue factor antibody and uses thereof
#159Method for obtaining anti-idiotype antibodies
#160Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
#161Prostatic cancer vaccine
#162Design of therapeutics and therapeutics
#163Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
#164Purified antigen for Alzheimer's disease and methods of obtaining and using same
#165Antibodies and uses thereof
#166Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
#167Antibodies with altered effector functions
#168Anti-idiotypic vascular endothelial growth factor antibodies and their use as medicaments
#169Anti-alpha3(IV)nc1 monoclonal antibodies and animal model for human anti-glomerular basement membrane autoantibody disease
#170Antibodies and uses thereof
#171Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides